Cu₂O/hollow mesoporous silica composites for the rapid and efficient removal of methylene blue

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

“…Additionally, the toxic side effects of these small molecule drugs limit the maximum dose that can be administered, ultimately leading to drug failure in the area of cancer therapy (Zhang et al 2023;Wendler et al 2021). To address this issue, several drug delivery vehicles, including liposomes (Chen et al 2014;Liu et al 2019), mesoporous silica (Wang et al 2018;Si et al 2024), albumin manganese dioxide (Liu et al 2012;Jiang et al 2024), andmicelles (Imran ul-haq et al 2013;Li et al 2020) have been developed and widely utilized in the tumor treatment field. These novel vehicles can improve drug properties and accumulate drugs at the tumor site through the permeation and retention (EPR) effect (Al-Harbi et al 2020;Pavitra et al 2021;Kalyanaraman et al 2019;Wang et al 2023).…”